글로벌 노로바이러스 치료 시장 - 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 글로벌 노로바이러스 치료 시장

노로바이러스 치료 시장은 2022-2029년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 5.50%의 CAGR로 성장할 것으로 분석합니다.

위장염을 유발하는 전형적인 바이러스 유형은 노로바이러스입니다. 위장관의 염증을 위장염이라고 합니다. 오염된 음식과 물, 그리고 감염된 개인과의 친밀한 접촉을 통해 감염이 퍼집니다. 노로바이러스는 매우 전염성이 강한 위와 장 바이러스입니다. 직접 또는 간접적으로 감염된 개인과 접촉함으로써 쉽게 전염됩니다. 설사, 구토, 메스꺼움, 복통, 몸살, 두통, 저열, 오한 등이 가장 흔한 노로바이러스 증상입니다. 이러한 증상은 종종 노출 후 12~48시간 후에 나타나며 최대 3일까지 지속될 수 있습니다.

노로바이러스 감염 유병률의 증가는 시장 성장 확대로 이어지는 주요 원동력으로 작용할 것입니다. 노로바이러스 치료 시장의 성장률에 영향을 미치는 또 다른 중요한 요인은 의료비 지출 증가입니다. 나아가 의료 기술의 발전, 공공 및 민간 기관의 인식 확산을 위한 이니셔티브 증가, 정부 자금 지원 증가는 노로바이러스 치료 시장을 확대할 요인입니다. 효과적인 치료법에 대한 수요 증가 및 정크푸드의 높은 소비와 같은 다른 요인은 노로바이러스 치료 시장의 성장률에 긍정적인 영향을 미칠 것입니다. 또한, 높은 가처분 소득과 변화하는 라이프스타일은 노로바이러스 치료 시장 확대로 이어질 것입니다.

Moreover, the rise in the research and development activities and launch of effective therapies will provide beneficial opportunities for the norovirus treatment market in the forecast period of 2022-2029. Also, fast-track government approvals of key drug candidates, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate norovirus treatment market in future.

However, high cost associated with the supportive treatment and lack of infrastructure in low-income countries will impede the growth rate of norovirus treatment market. Additionally, complications involved with norovirus infection and rising product recalls will hinder the norovirus treatment market growth. Less awareness about contamination through personal items will further challenge the market in the forecast period mentioned above.

This norovirus treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Norovirus treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Norovirus Treatment Market Scope and Market Size

The norovirus treatment market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the norovirus treatment market is segmented into electrolytes, intravenous fluids, antipyretics, analgesics, anti-diarrheal, and others.
• On the basis of diagnosis, the norovirus treatment market is segmented into bacteria culture test, stool tests and others.
• On the basis of symptoms, the norovirus treatment market is segmented into diarrhea, vomiting, nausea, stomach pain, body aches, headaches, low-grade fever, chills and others.
• On the basis of dosage, the norovirus treatment market is segmented into injection, tablets, and others.
• On the basis of route of administration, the norovirus treatment market is segmented into oral, intravenous and others.
• On the basis of end-users, the norovirus treatment market is segmented into clinic, hospital and others.

The norovirus treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Norovirus Treatment Market Country Level Analysis

The norovirus treatment market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel.

The countries covered in the norovirus treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the norovirus treatment market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Norovirus treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Norovirus Treatment Market Share Analysis

노로바이러스 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 노로바이러스 치료 시장 조사와 관련된 회사의 초점에만 관련이 있습니다.

노로바이러스 치료 시장의 주요 기업으로는 F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, AbbVie Inc., Pfizer Inc., Sanofi, Aurobindo Pharma, Mylan NV, GlaxoSmithKline plc, Cipla Inc., Sun Pharmaceutical Industries Ltd., Abbott, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Eli Lilly and Company, Lupin, Reckitt Benckiser Group PLC, Endo International plc, Bristol-Myers Squibb Company, Bayer AG 등이 있습니다.

SKU-67810